Results 161 to 170 of about 211,400 (307)

MagmaFlow: A desktop platform for artificial intelligence‐driven expression analysis

FEBS Open Bio, EarlyView.
MagmaFlow is a free, no‐code platform for gene expression analysis. It generates interactive volcano plots, links genes to literature, pathways, and diseases, prioritizes candidates using millions of publications, identifies affected biological processes, builds network diagrams, and exports publication‐ready figures and reports for macOS and Windows ...
Carlos E. Buss, Ao Li, Eduardo H. Gilglioni, Mayank Bansal, Sumeet Pal Singh, Latifa Bakiri, Alessandra K. Cardozo, Esteban N. Gurzov   +7 more
wiley   +1 more source

Carbon quantum dots as transcutaneous drug carriers: mechanisms, challenges and prospects. [PDF]

RSC Adv
Venugopal V, Kumar BS, Reddy SG, Thota SM.   +3 more
europepmc   +1 more source

Polymer-lipid hybrid nanoparticles as potential lipophilic anticancer drug carriers. [PDF]

Discov Nano, 2023
Salel S, Iyisan B.
europepmc   +1 more source

Aging Is a Key Driver for Adult Acute Myeloid Leukemia

Aging and Cancer, EarlyView.
Acute myeloid leukemia (AML) is a classical age‐related hematologic malignancy, and a key driver of AML is aging, which profoundly regulates intrinsic factors such as genomic instability, epigenetic reprogramming, and metabolic dysregulation, and alters bone marrow microenvironment.
Rong Yin, Haojian Zhang
wiley   +1 more source

Tumor-targeted multifunctional extracellular vesicles as drug carriers for lung cancer therapy. [PDF]

Extracell Vesicles Circ Nucl Acids
Amreddy N, Srivastava A, Riedinger N, Ragothaman M, Zhao YD, Gali H, Munshi A, Ramesh R.   +7 more
europepmc   +1 more source

Mutant NPM1 in Acute Myeloid Leukemia Initiation and Maintenance

Aging and Cancer, EarlyView.
NPM1 mutations drive acute myeloid leukemia by acting as neomorphic transcriptional regulators that cooperate with Menin–MLL and XPO1 to sustain HOX/MEIS1 expression and block differentiation. Targeting these mutant‐specific transcriptional dependencies provides a rational therapeutic strategy for NPM1‐mutated AML.
Yanan Jiang, Zhong Fan, Runmeng Liu, Xiaotian Zhang   +3 more
wiley   +1 more source

Functionalization of carbon nanospheres with curcumin, polyethylene glycol and folic acid: potential use as drug carriers. [PDF]

RSC Adv
De Sales L, Bernal-Chávez SA, Campos-Delgado J.   +2 more
europepmc   +1 more source

Biomimetic Collagen Membranes as Drug Carriers of Geranylgeraniol to Counteract the Effect of Zoledronate. [PDF]

Biomimetics (Basel), 2023
Manzano-Moreno FJ, de Luna-Bertos E, Toledano-Osorio M, Urbano-Arroyo P, Ruiz C, Toledano M, Osorio R.   +6 more
europepmc   +1 more source

Super‐Refractory Status Epilepticus (SRSE) in a Patient With Compound Heterozygous OPA1 Variants: Case Report and Literature Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Super‐Refractory Status Epilepticus (SRSE) is a rare, life‐threatening neurological emergency with unclear etiology in many cases. Mitochondrial dysfunction, often due to disease‐causing genetic variants, is increasingly recognized as a cause, with each gene producing distinct pathophysiological mechanisms.
Pouria Mohammadi, Lara Basovic, Christopher Michael McGraw   +2 more
wiley   +1 more source

Editorial: Driving extracellular vesicles toward applications in precision medicine

Frontiers in Medicine, 2022
Somchai Chutipongtanate, Somchai Chutipongtanate, Somchai Chutipongtanate, Somchai Chutipongtanate, Kovit Pattanapanyasat, Jarek Meller, Jarek Meller, Jarek Meller, Juana Serrano López   +8 more
doaj   +1 more source